Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent

Details for Australian Patent Application No. 2004308378 (hide)

Owner Regenerx Biopharmaceuticals, Inc.

Inventors Goldstein, Allan L.

Agent Wrays

Pub. Number AU-B-2004308378

PCT Pub. Number WO2005/062864

Priority 60/530,893 22.12.03 US

Filing date 22 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 13 May 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/062864 Priority application(s): WO2005/062864

13 May 2010 Application Accepted

  Published as AU-B-2004308378

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308379-Optically encoded particles with grey scale spectra

2004308377-Method and system for providing targeted graphical advertisements